Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 43Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 13Lung Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Melanoma 12Head and Neck Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Carcinoma, Renal Cell 11Rectal Neoplasms 10Prostatic Neoplasms 9Carcinoma, Ovarian Epithelial 8Ovarian Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms, Male 7Salivary Gland Neoplasms 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Liver Neoplasms 6Stomach Neoplasms 5Precancerous Conditions 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, Large B-Cell, Diffuse 5Kidney Neoplasms 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Adenocarcinoma Of Esophagus 5Uterine Cervical Neoplasms 4

Interventions

Fluorodeoxyglucose F18 7Irinotecan 4Fluorouracil 4Cyclophosphamide 4Bevacizumab 4toripalimab 3pembrolizumab 3olaparib 3Radiosurgery 3Cisplatin 3Capecitabine 3vistusertib 2tislelizumab 2spartalizumab 2fludarabine 2atezolizumab 2apatinib 2Temozolomide 2Technetium 2Specimen Handling 2Sirolimus 2Radiotherapy 2Proton Therapy 2Paclitaxel 2Leucovorin 2Letrozole 2Hydroxychloroquine 2Everolimus 2Drug Therapy 2Docetaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solid Tumor × Immunohistochemistry × Clear all
NCT00483457 2012-09-03

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Vanderbilt-Ingram Cancer Center

Completed
33 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡